Cardinal Health Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2024 Annual Meeting of Shareholders held on November 6, 2024. The filing details the voting outcomes for four proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following outcomes were reported for the four proposals:
- Proposal 1 (Director Elections): All 10 nominees were elected. However, three directors received significant "Against" votes: Gregory B. Kenny (15,477,787 against), Patricia A. Hemingway Hall (8,127,441 against), and Nancy Killefer (7,720,227 against).
- Proposal 2 (Say-on-Pay): Shareholders approved the executive compensation advisory vote with 172,738,569 votes for and 19,964,307 votes against.
- Proposal 3 (Auditor Ratification): Shareholders ratified the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending June 30, 2025.
- Proposal 4 (Shareholder Proposal): Shareholders did not approve a proposal to prohibit the re-nomination of directors failing to receive a majority vote. The vote was 36,980,168 for and 155,556,799 against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the voting results.
Key Facts for Investor Verification
- Verify the Company's response to the significant "Against" votes received by Directors Kenny, Hall, and Killefer.
- Confirm the specific reasons cited by shareholders for rejecting the majority-vote director re-nomination proposal (Proposal 4).
- Review the definitive proxy statement filed on September 16, 2024, for detailed context on the director nominees and executive compensation.